Autres langues Kodiak Sciences Inc.

Actions

KOD

US50015M1099

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
2,89 ^USD	-3,99 %		-9,12 %	-4,93 %

15/05	Kodiak Sciences Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
14/05	Kodiak Sciences Inc. annonce le traitement des premiers patients de l'étude de phase 3 GLOW2 sur le tarcocimab Tedromer dans la rétinopathie diabétique	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences	29/05
Kodiak Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results	15/05
Diabetic Retinopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	15/05
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy	14/05
Kodiak Sciences Inc. Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy	14/05
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform	02/05
Kodiak Sciences Inc. Announces Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate Platform	02/05
Sector Update: Health Care Stocks Rise Late Afternoon	28/03
Sector Update: Health Care	28/03
Top Midday Decliners	28/03
Kodiak Sciences Shares Tumble After Wider-Than-Expected Q4 Loss	28/03
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results	28/03
Kodiak Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Kodiak Sciences Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024	26/03
Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting	30/01
Ausblick Lonza: Jahresumsatz von 6,5 Milliarden Franken erwartet	25/01
Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	04/01
Kodiak Sciences Inc.(NasdaqGM:KOD) dropped from NASDAQ Biotechnology Index	15/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Kodiak Sciences Inc.

Actions

KOD

US50015M1099

Autres langues

Filtres